Showing 7621-7630 of 10402 results for "".
- Houston Surgeon Performs Breakthrough Robotic Hair Restorationhttps://practicaldermatology.com/news/20130402-houston_surgeon_performs_breakthrough_robotic_hair_restoration/2459574/Restoration Robotics, Inc. installed its revolutionary ARTAS System at the Mosaic Clinic in Houston, TX. Dr. Rashid Rashid is one of the few hair physicians in the country to hold both MD and PhD degrees and an enhanced background in r
- New Survey Finds Social Media is a Major Influence on Elective Surgeryhttps://practicaldermatology.com/news/20130327-new_survey_finds_social_media_is_a_major_influence_on_elective_surgery/2459578/Social media is leading consumers to have a more self-critical eye, according to a new survey by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). The annual poll of the organization's board-certified facial plastic surgeons found a 31 percent increase in requests for surge
- Skin Cancer Foundation Inducts Dr. Amy Forman Taub into its Amonette Circlehttps://practicaldermatology.com/news/20130327-skin_cancer_foundation_inducts_amy_forman_taub_md_into_its_amonette_circle/2459579/Amy Forman Taub, MD, was recently inducted into the Skin Cancer Foundation's Amonette Circle at the American Academy of Dermatology Annual Meeting in Miami, FL. Amonette Circle is a lifetime membership comprised of physicians who make an outstanding commitment to The Skin Cancer Foundation's mission
- La Roche-Posay and WDS Expand Sun Protection Campaignhttps://practicaldermatology.com/news/20130320-la_roche-posay_and_wds_expand_sun_protection_campaign/2459583/La Roche-Posay and the Women's Dermatologic Society (WDS) are taking their Time Out, Protect Your Skin (TOPS) initiative national. Launching this year in five public and private schools across the country, the TOPS program will increase awareness about sun protection and instill good skin health hab
- On Match Day, AMA Calls for Additional Residency Positions to Address Physician Shortagehttps://practicaldermatology.com/news/20130319-on_match_day_ama_calls_for_additional_residency_positions_to_address_physician_shortage/2459585/A statement released by Jeremy A. Lazarus, M.D., President of the American Medical Association, is seeking to raise awareness about the physician shortage. "Today, on Match Day, thousands of medical students will learn where they will complete their graduate medical education (GME), known as reside
- SkinMedica Unveils Hydroquinone-Free Skin Brightening Complexhttps://practicaldermatology.com/news/20130314-skinmedica_unveils_hydroquinone-free_skin_brightening_complex/2459588/SkinMedica introduced its new skin brightening product, SkinMedica Lytera™ Skin Brightening Complex, a hydroquinone-free product that reduces the appearance of skin discoloration and dark spots. Featuring a proprietary blend of ingredients, SkinMedica Lytera™ Skin Brightening Complex works to bright
- AMBI Skincare Announces Annual Skin of Color Society Research Awardhttps://practicaldermatology.com/news/20130312-ambi_skincare_announces_annual_skin_of_color_society_research_award/2459592/The annual AMBI Skin of Color Society Research Award was recently presented to Jenna O'Neill, MD, for her contribution to dermatological research in skin of color, specifically in characterizing the genetic basis of central centrifugal cicatricial alopecia. The Award is sponsored by a $15,000 grant
- Envy Medical Unveils New Acne Systemhttps://practicaldermatology.com/news/20130311-envy_medical_unveils_new_acne_system/2459595/Envy Medical Inc. recently launched the ClarityMD Acne Solution at the American Academy of Dermatology Annual Meeting on March 1 in Miami. The system includes a Deep Pore Cleanser and Clarifying Gel in a two-step system that's clinically proven to significantly heal acne within days, according to th
- Investigational Injectable Found Safe, Effective for Submental Fathttps://practicaldermatology.com/news/20130311-investigational_injectable_found_safe_effective_for_submental_fat/2459596/An investigational injectable drug for the reduction of submental fat called ATX-101 from Kythera Biopharmaceuticals was found both safe and effective in new data presented at the AAD Meeting in Miami. In the open-label Phase IIIb study, interim results three months after the last ATX-101 treatment
- Apremilast Phase III Results Show Efficacy Over Time for Psoriasishttps://practicaldermatology.com/news/20130311-apremilast_phase_iii_results_show_efficacy_over_time_for_psoriasis/2459597/Results from a new Phase III study presented at the AAD Meeting in Miami demonstrate the efficacy of the oral molecule apremilast (Celgene) in psoriasis patients. The ESTEEM 1 study evaluated efficacy and safety in a range of patients, approximately one-third of which was systemic and/or phototherap